Farther Finance Advisors, LLC

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1992825 SAN FRANCISCO, CA

Position in UTHR

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$485,057

+$47,994 QoQ

Shares Held

818

-8.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2022

14 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

Farther Finance Advisors, LLC holds $5,648,119 across 52 Drug Manufacturers - Specialty & Generic names. UTHR ranks #3 (8.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	11,645	$1,376,555
2	VTRS	Viatris Inc	43,117	$582,510
3	UTHR	UNITED THERAPEUTICS Corp This page	818	$485,057
4	HIMS	Hims & Hers Health, Inc.	20,825	$432,327
5	NBIX	Neurocrine Biosciences Inc	2,947	$388,237
6	COLL	Collegium Pharmaceutical, Inc	11,677	$386,158
7	TEVA	Teva Pharmaceutical Industries Ltd	11,152	$335,898
8	TAK	Takeda Pharmaceutical Co Ltd	17,828	$330,174

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$485,057	818	-8.8%	Shares	Sole	2026-04-07
2025-12-31	$437,063	897	+406.8%	Shares	Sole	2026-01-23
2025-09-30	$74,200	177	+149.3%	Shares	Sole	2025-10-14
2025-06-30	$20,401	71	-84.4%	Shares	Sole	2025-07-11
2025-03-31	$140,571	456	+20.3%	Shares	Sole	2025-04-14
2024-12-31	$133,726	379	+6.5%	Shares	Sole	2025-02-10
2024-09-30	$127,572	356	+673.9%	Shares	Sole	2024-10-29
2024-06-30	$14,653	46	+35.3%	Shares	Sole	2024-07-31
2024-03-31	$7,810	34	-45.2%	Shares	Sole	2024-05-14
2023-12-31	$13,633	62	+51.2%	Shares	Sole	2024-02-15
2023-09-30	$9,260	41	-2.4%	Shares	Sole	2023-11-14
2023-06-30	$9,271	42	+20.0%	Shares	Sole	2024-05-14
2023-03-31	$7,838	35	0.0%	Shares	Sole	2024-05-14
2022-12-31	$9,733	35	—	Shares	Sole	2023-09-12
No filing history on record for this holder in this stock.